Legal & General Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,564
| Closed | -$4.7M | – | 3583 |
|
|
2021
Q4 | $4.7M | Buy |
50,564
+800
| +2% | +$52.7K | ﹤0.01% | 1596 |
|
|
2021
Q3 | $2.96M | Buy |
49,764
+11,297
| +29% | +$667K | ﹤0.01% | 1825 |
|
|
2021
Q2 | $2.62M | Sell |
38,467
-778
| -2% | -$50.7K | ﹤0.01% | 1850 |
|
|
2021
Q1 | $2.72M | Buy |
39,245
+4,754
| +14% | +$366K | ﹤0.01% | 1846 |
|
|
2020
Q4 | $2.65M | Sell |
34,491
-435
| -1% | -$32.6K | ﹤0.01% | 1773 |
|
|
2020
Q3 | $2.61M | Buy |
34,926
+1,533
| +5% | +$102K | ﹤0.01% | 1656 |
|
|
2020
Q2 | $2.1M | Sell |
33,393
-1,171
| -3% | -$64.4K | ﹤0.01% | 1714 |
|
|
2020
Q1 | $1.45M | Sell |
34,564
-1,379
| -4% | -$63.2K | ﹤0.01% | 1721 |
|
|
2019
Q4 | $1.63M | Buy |
35,943
+6,679
| +23% | +$316K | ﹤0.01% | 1891 |
|
|
2019
Q3 | $1.34M | Buy |
29,264
+3,468
| +13% | +$195K | ﹤0.01% | 1881 |
|
|
2019
Q2 | $1.51M | Buy |
25,796
+5,530
| +27% | +$286K | ﹤0.01% | 1812 |
|
|
2019
Q1 | $908K | Buy |
20,266
+414
| +2% | +$19K | ﹤0.01% | 1993 |
|
|
2018
Q4 | $773K | Buy |
19,852
+1,218
| +7% | +$47.8K | ﹤0.01% | 1988 |
|
|
2018
Q3 | $858K | Buy |
18,634
+10,688
| +135% | +$433K | ﹤0.01% | 1992 |
|
|
2018
Q2 | $347K | Sell |
7,946
-797
| -9% | -$34.3K | ﹤0.01% | 2190 |
|
|
2018
Q1 | $345K | Sell |
8,743
-1,151
| -12% | -$44.8K | ﹤0.01% | 2198 |
|
|
2017
Q4 | $337K | Sell |
9,894
-462
| -4% | -$13.2K | ﹤0.01% | 2185 |
|
|
2017
Q3 | $264K | Buy |
10,356
+3,302
| +47% | +$75.7K | ﹤0.01% | 2249 |
|
|
2017
Q2 | $117K | Buy |
7,054
+1,140
| +19% | +$15.6K | ﹤0.01% | 2525 |
|
|
2017
Q1 | $86K | Sell |
5,914
-1,861
| -24% | -$27.6K | ﹤0.01% | 2630 |
|
|
2016
Q4 | $111K | Buy |
7,775
+2,504
| +48% | +$38.8K | ﹤0.01% | 2499 |
|
|
2016
Q3 | $92K | Hold |
5,271
| – | – | ﹤0.01% | 2250 |
|
|
2016
Q2 | $91K | Hold |
5,271
| – | – | ﹤0.01% | 2151 |
|
|
2016
Q1 | $104K | Sell |
5,271
-8
| -0.2% | -$128 | ﹤0.01% | 2021 |
|
|
2015
Q4 | $101K | Hold |
5,279
| – | – | ﹤0.01% | 2071 |
|
|
2015
Q3 | $104K | Hold |
5,279
| – | – | ﹤0.01% | 2017 |
|
|
2015
Q2 | $236K | Buy |
5,279
+1,059
| +25% | +$45.9K | ﹤0.01% | 1673 |
|
|
2015
Q1 | $190K | Buy |
4,220
+984
| +30% | +$45.7K | ﹤0.01% | 1703 |
|
|
2014
Q4 | $113K | Hold |
3,236
| – | – | ﹤0.01% | 1883 |
|
|
2014
Q3 | $135K | Buy |
+3,236
| New | +$144K | ﹤0.01% | 1712 |
|
Legal & General Group's ARNA Position: Q1 2022 in Review
Legal & General Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 50,564 shares — an estimated $4.7M sold.
Legal & General Group first reported a position in ARNA in Q3 2014 and held it in 30 quarters. The position peaked at $4.7M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Legal & General Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Legal & General Group sold 50,564 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $4.7M.
- Legal & General Group first reported a position in Arena Pharmaceuticals Inc in Q3 2014 and held it in 30 quarters.
- Legal & General Group's Arena Pharmaceuticals Inc position peaked at $4.7M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Legal & General Group's 13F filing for Q1 2022, filed 16 May 2022.